295 results on '"Armour, Carol L."'
Search Results
2. Patient Preferences for Managing Insomnia: A Discrete Choice Experiment
3. Pharmacy asthma services - will evidence alone sustain them?
4. Receptor for advanced glycation end products and its ligand high-mobility group box-1 mediate allergic airway sensitization and airway inflammation
5. Primary health care teams and the patient perspective: A social network analysis
6. Multidisciplinary collaboration in primary care: Through the eyes of patients
7. Multidisciplinary Asthma Care Teams: The Role of the Specialist Pharmacist
8. Be our guest: What services can COPD patients expect from pharmacists?
9. Patient asthma networks: understanding who is important and why
10. A pharmacy asthma service achieves a change in patient responses from increased awareness to taking responsibility for their asthma
11. Corticosteroids Inhibit Sphingosine 1-Phosphate-Induced Interleukin-6 Secretion from Human Airway Smooth Muscle via Mitogen-Activated Protein Kinase Phosphatase 1-Mediated Repression of Mitogen and Stress-Activated Protein Kinase 1
12. RAGE and TLRs: Relatives, friends or neighbours?
13. IL-17A acts via p38 MAPK to increase stability of TNF-[alpha]-induced IL-8 mRNA in human ASM
14. Consumer Preference for Dinoprostone Vaginal Gel Using Stated Preference Discrete Choice Modelling
15. RAGE: a new frontier in chronic airways disease
16. Cost-Benefit Analysis of a Haemophilus Influenzae Type B Meningitis Prevention Programme in The Philippines
17. Factors controlling transduction signaling and proliferation of airway smooth muscle
18. Human mast cell and airway smooth muscle cell interactions: implications for asthma. (invited review)
19. Cost Implications in the Management of Induction of Labour
20. Improved asthma outcomes with a simple inhaler technique intervention by community pharmacists
21. Drug Utilisation Review (DUR) of the Third Generation Cephalosporins: Focus on Ceftriaxone, Ceftazidime and Cefotaxime
22. Complementary and alternative medicine use in asthma: Who is using what?
23. A cost-effectiveness analysis of a community pharmacist-initiated disease state management service for type 2 diabetes mellitus
24. CD40 and OX40 ligand are increased on stimulated asthmatic airway smooth muscle
25. Endothelin receptors and activity differ in human, dog, and rabbit lung
26. IL-17A augments TNF-α–induced IL-6 expression in airway smooth muscle by enhancing mRNA stability
27. ‘Proliferative’ and ‘synthetic’ airway smooth muscle cells are overlapping populations
28. DIFFERENTIAL MODULATION OF HUMAN AIRWAY SMOOTH MUSCLE CELL CYTOKINE PRODUCTION BY TRYPTASE
29. Heparin and PGE2 inhibit DNA synthesis in human airway smooth muscle cells in culture
30. GROWTH FACTORS AND THROMBIN POTENTIATE CYTOKINE-INDUCED HUMAN AIRWAY SMOOTH MUSCLE CELL GM-CSF PRODUCTION
31. Acceptability of willingness to pay techniques to consumers
32. PROLIFERATING AND NON-PROLIFERATING HUMAN AIRWAY SMOOTH MUSCLE CELLS (ASMC) SECRETE GM-CSF
33. Tumour necrosis factor-α potentiates contraction of human bronchus in vitro
34. Thiazolidinediones inhibit airway smooth muscle release of the chemokine CXCL10: in vitro comparison with current asthma therapies
35. Smooth-Muscle Myosin Light-Chain Kinase Content Is Increased in Human Sensitized Airways
36. Experiences of community pharmacists involved in the delivery of a specialist asthma service in Australia
37. Airway Structure and Function in Eisenmengerʼs Syndrome
38. Treatment burden should be included in clinical practice guidelines
39. Sensitization Decreases Relaxation in Human Isolated Airways
40. The Action of a Potassium Channel Activator, BRL 38227 (Lemakalim), on Human Airway Smooth Muscle
41. An epithelial-derived factor inhibits contraction in canine perfused bronchial segments
42. Physicians' perspectives on communication and decision making in clinical encounters for treatment of latent tuberculosis infection
43. Patient Perceptions of Treatment Delivery Platforms for Cognitive Behavioral Therapy for Insomnia
44. An exploration of clinical interventions provided by pharmacists within a complex asthma service
45. Patient Perceptions of Treatment Delivery Platforms for Cognitive Behavioral Therapy for Insomnia.
46. Using scenarios to test the appropriateness of pharmacist prescribing in asthma management
47. The role of community pharmacists in screening and subsequent management of chronic respiratory diseases: a systematic review
48. Management of hypertension in an Australian community pharmacy setting – patients’ beliefs and perspectives
49. Implementation and evaluation of a pharmacist-led hypertension management service in primary care: outcomes and methodological challenges
50. To Drug or Not to Drug: A Qualitative Study of Patients’ Decision-Making Processes for Managing Insomnia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.